世界の診断エクソソームバイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diagnostic Exosome Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4127 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、診断エクソソームバイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（膜結合タンパク質、可溶性タンパク質、ノンコーディングRNA、その他）、用途別市場規模（病院、クリニック、外来外科センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・診断エクソソームバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・診断エクソソームバイオマーカーの種類別市場規模と予測2016-2027（膜結合タンパク質、可溶性タンパク質、ノンコーディングRNA、その他） ・診断エクソソームバイオマーカーの用途別市場規模と予測2016-2027（病院、クリニック、外来外科センター） ・診断エクソソームバイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・診断エクソソームバイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・診断エクソソームバイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・診断エクソソームバイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・診断エクソソームバイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（101Bio、AMS Biotechnology、BioRegenerative Sciences、Cell Guidance Systems、Codiak BioSciences、Evomic Science、ExoCyte Therapeutics、Bio-Techne、Exovita biosciences、Immune Therapy Holdings、Lonza、Norgen Biotek、ReNeuron Group、Therapeutic Solutions International） ・結論

The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The exosomes are released in easily accessible body fluids such as urine and blood and hence acts as a precious source of biomedical tool. As cancer is a booming research area, exosomes may act as a very useful biomarkers for the diagnosis and prognosis of malignant tumor. The application of exosome as a potential biomarker for the various neurodegenerative disorders is also under investigation.

Market Analysis and Insights: Global Diagnostic Exosome Biomarker Market
The global Diagnostic Exosome Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Exosome Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Exosome Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Exosome Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Exosome Biomarker market.

Global Diagnostic Exosome Biomarker Scope and Market Size
Diagnostic Exosome Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Exosome Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Membrane-bound Proteins
Soluble Proteins
Noncoding RNA
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
101Bio
AMS Biotechnology
BioRegenerative Sciences
Cell Guidance Systems
Codiak BioSciences
Evomic Science
ExoCyte Therapeutics
Bio-Techne
Exovita biosciences
Immune Therapy Holdings
Lonza
Norgen Biotek
ReNeuron Group
Therapeutic Solutions International

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Membrane-bound Proteins
1.2.3 Soluble Proteins
1.2.4 Noncoding RNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Diagnostic Exosome Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diagnostic Exosome Biomarker Market Perspective (2016-2027)
2.2 Diagnostic Exosome Biomarker Growth Trends by Regions
2.2.1 Diagnostic Exosome Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diagnostic Exosome Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Diagnostic Exosome Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Diagnostic Exosome Biomarker Industry Dynamic
2.3.1 Diagnostic Exosome Biomarker Market Trends
2.3.2 Diagnostic Exosome Biomarker Market Drivers
2.3.3 Diagnostic Exosome Biomarker Market Challenges
2.3.4 Diagnostic Exosome Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Exosome Biomarker Players by Revenue
3.1.1 Global Top Diagnostic Exosome Biomarker Players by Revenue (2016-2021)
3.1.2 Global Diagnostic Exosome Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Diagnostic Exosome Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Exosome Biomarker Revenue
3.4 Global Diagnostic Exosome Biomarker Market Concentration Ratio
3.4.1 Global Diagnostic Exosome Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Exosome Biomarker Revenue in 2020
3.5 Diagnostic Exosome Biomarker Key Players Head office and Area Served
3.6 Key Players Diagnostic Exosome Biomarker Product Solution and Service
3.7 Date of Enter into Diagnostic Exosome Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Exosome Biomarker Breakdown Data by Type
4.1 Global Diagnostic Exosome Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2022-2027)

5 Diagnostic Exosome Biomarker Breakdown Data by Application
5.1 Global Diagnostic Exosome Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diagnostic Exosome Biomarker Market Size (2016-2027)
6.2 North America Diagnostic Exosome Biomarker Market Size by Type
6.2.1 North America Diagnostic Exosome Biomarker Market Size by Type (2016-2021)
6.2.2 North America Diagnostic Exosome Biomarker Market Size by Type (2022-2027)
6.2.3 North America Diagnostic Exosome Biomarker Market Size by Type (2016-2027)
6.3 North America Diagnostic Exosome Biomarker Market Size by Application
6.3.1 North America Diagnostic Exosome Biomarker Market Size by Application (2016-2021)
6.3.2 North America Diagnostic Exosome Biomarker Market Size by Application (2022-2027)
6.3.3 North America Diagnostic Exosome Biomarker Market Size by Application (2016-2027)
6.4 North America Diagnostic Exosome Biomarker Market Size by Country
6.4.1 North America Diagnostic Exosome Biomarker Market Size by Country (2016-2021)
6.4.2 North America Diagnostic Exosome Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diagnostic Exosome Biomarker Market Size (2016-2027)
7.2 Europe Diagnostic Exosome Biomarker Market Size by Type
7.2.1 Europe Diagnostic Exosome Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Diagnostic Exosome Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Diagnostic Exosome Biomarker Market Size by Type (2016-2027)
7.3 Europe Diagnostic Exosome Biomarker Market Size by Application
7.3.1 Europe Diagnostic Exosome Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Diagnostic Exosome Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Diagnostic Exosome Biomarker Market Size by Application (2016-2027)
7.4 Europe Diagnostic Exosome Biomarker Market Size by Country
7.4.1 Europe Diagnostic Exosome Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Diagnostic Exosome Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type
8.2.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application
8.3.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region
8.4.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diagnostic Exosome Biomarker Market Size (2016-2027)
9.2 Latin America Diagnostic Exosome Biomarker Market Size by Type
9.2.1 Latin America Diagnostic Exosome Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Diagnostic Exosome Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Diagnostic Exosome Biomarker Market Size by Type (2016-2027)
9.3 Latin America Diagnostic Exosome Biomarker Market Size by Application
9.3.1 Latin America Diagnostic Exosome Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Diagnostic Exosome Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Diagnostic Exosome Biomarker Market Size by Application (2016-2027)
9.4 Latin America Diagnostic Exosome Biomarker Market Size by Country
9.4.1 Latin America Diagnostic Exosome Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Diagnostic Exosome Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type
10.2.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application
10.3.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country
10.4.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 101Bio
11.1.1 101Bio Company Details
11.1.2 101Bio Business Overview
11.1.3 101Bio Diagnostic Exosome Biomarker Introduction
11.1.4 101Bio Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.1.5 101Bio Recent Development
11.2 AMS Biotechnology
11.2.1 AMS Biotechnology Company Details
11.2.2 AMS Biotechnology Business Overview
11.2.3 AMS Biotechnology Diagnostic Exosome Biomarker Introduction
11.2.4 AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.2.5 AMS Biotechnology Recent Development
11.3 BioRegenerative Sciences
11.3.1 BioRegenerative Sciences Company Details
11.3.2 BioRegenerative Sciences Business Overview
11.3.3 BioRegenerative Sciences Diagnostic Exosome Biomarker Introduction
11.3.4 BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.3.5 BioRegenerative Sciences Recent Development
11.4 Cell Guidance Systems
11.4.1 Cell Guidance Systems Company Details
11.4.2 Cell Guidance Systems Business Overview
11.4.3 Cell Guidance Systems Diagnostic Exosome Biomarker Introduction
11.4.4 Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.4.5 Cell Guidance Systems Recent Development
11.5 Codiak BioSciences
11.5.1 Codiak BioSciences Company Details
11.5.2 Codiak BioSciences Business Overview
11.5.3 Codiak BioSciences Diagnostic Exosome Biomarker Introduction
11.5.4 Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.5.5 Codiak BioSciences Recent Development
11.6 Evomic Science
11.6.1 Evomic Science Company Details
11.6.2 Evomic Science Business Overview
11.6.3 Evomic Science Diagnostic Exosome Biomarker Introduction
11.6.4 Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.6.5 Evomic Science Recent Development
11.7 ExoCyte Therapeutics
11.7.1 ExoCyte Therapeutics Company Details
11.7.2 ExoCyte Therapeutics Business Overview
11.7.3 ExoCyte Therapeutics Diagnostic Exosome Biomarker Introduction
11.7.4 ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.7.5 ExoCyte Therapeutics Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne Diagnostic Exosome Biomarker Introduction
11.8.4 Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.8.5 Bio-Techne Recent Development
11.9 Exovita biosciences
11.9.1 Exovita biosciences Company Details
11.9.2 Exovita biosciences Business Overview
11.9.3 Exovita biosciences Diagnostic Exosome Biomarker Introduction
11.9.4 Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.9.5 Exovita biosciences Recent Development
11.10 Immune Therapy Holdings
11.10.1 Immune Therapy Holdings Company Details
11.10.2 Immune Therapy Holdings Business Overview
11.10.3 Immune Therapy Holdings Diagnostic Exosome Biomarker Introduction
11.10.4 Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.10.5 Immune Therapy Holdings Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Diagnostic Exosome Biomarker Introduction
11.11.4 Lonza Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.11.5 Lonza Recent Development
11.12 Norgen Biotek
11.12.1 Norgen Biotek Company Details
11.12.2 Norgen Biotek Business Overview
11.12.3 Norgen Biotek Diagnostic Exosome Biomarker Introduction
11.12.4 Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.12.5 Norgen Biotek Recent Development
11.13 ReNeuron Group
11.13.1 ReNeuron Group Company Details
11.13.2 ReNeuron Group Business Overview
11.13.3 ReNeuron Group Diagnostic Exosome Biomarker Introduction
11.13.4 ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.13.5 ReNeuron Group Recent Development
11.14 Therapeutic Solutions International
11.14.1 Therapeutic Solutions International Company Details
11.14.2 Therapeutic Solutions International Business Overview
11.14.3 Therapeutic Solutions International Diagnostic Exosome Biomarker Introduction
11.14.4 Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2016-2021)
11.14.5 Therapeutic Solutions International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Membrane-bound Proteins
Table 3. Key Players of Soluble Proteins
Table 4. Key Players of Noncoding RNA
Table 5. Key Players of Others
Table 6. Global Diagnostic Exosome Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diagnostic Exosome Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diagnostic Exosome Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diagnostic Exosome Biomarker Market Share by Regions (2016-2021)
Table 10. Global Diagnostic Exosome Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diagnostic Exosome Biomarker Market Share by Regions (2022-2027)
Table 12. Diagnostic Exosome Biomarker Market Trends
Table 13. Diagnostic Exosome Biomarker Market Drivers
Table 14. Diagnostic Exosome Biomarker Market Challenges
Table 15. Diagnostic Exosome Biomarker Market Restraints
Table 16. Global Diagnostic Exosome Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diagnostic Exosome Biomarker Market Share by Players (2016-2021)
Table 18. Global Top Diagnostic Exosome Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Exosome Biomarker as of 2020)
Table 19. Ranking of Global Top Diagnostic Exosome Biomarker Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diagnostic Exosome Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diagnostic Exosome Biomarker Product Solution and Service
Table 23. Date of Enter into Diagnostic Exosome Biomarker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2016-2021)
Table 27. Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diagnostic Exosome Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diagnostic Exosome Biomarker Revenue Market Share by Application (2016-2021)
Table 31. Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diagnostic Exosome Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diagnostic Exosome Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diagnostic Exosome Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diagnostic Exosome Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diagnostic Exosome Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diagnostic Exosome Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diagnostic Exosome Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diagnostic Exosome Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diagnostic Exosome Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diagnostic Exosome Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diagnostic Exosome Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diagnostic Exosome Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diagnostic Exosome Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diagnostic Exosome Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diagnostic Exosome Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diagnostic Exosome Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 63. 101Bio Company Details
Table 64. 101Bio Business Overview
Table 65. 101Bio Diagnostic Exosome Biomarker Product
Table 66. 101Bio Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 67. 101Bio Recent Development
Table 68. AMS Biotechnology Company Details
Table 69. AMS Biotechnology Business Overview
Table 70. AMS Biotechnology Diagnostic Exosome Biomarker Product
Table 71. AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 72. AMS Biotechnology Recent Development
Table 73. BioRegenerative Sciences Company Details
Table 74. BioRegenerative Sciences Business Overview
Table 75. BioRegenerative Sciences Diagnostic Exosome Biomarker Product
Table 76. BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 77. BioRegenerative Sciences Recent Development
Table 78. Cell Guidance Systems Company Details
Table 79. Cell Guidance Systems Business Overview
Table 80. Cell Guidance Systems Diagnostic Exosome Biomarker Product
Table 81. Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 82. Cell Guidance Systems Recent Development
Table 83. Codiak BioSciences Company Details
Table 84. Codiak BioSciences Business Overview
Table 85. Codiak BioSciences Diagnostic Exosome Biomarker Product
Table 86. Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 87. Codiak BioSciences Recent Development
Table 88. Evomic Science Company Details
Table 89. Evomic Science Business Overview
Table 90. Evomic Science Diagnostic Exosome Biomarker Product
Table 91. Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 92. Evomic Science Recent Development
Table 93. ExoCyte Therapeutics Company Details
Table 94. ExoCyte Therapeutics Business Overview
Table 95. ExoCyte Therapeutics Diagnostic Exosome Biomarker Product
Table 96. ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 97. ExoCyte Therapeutics Recent Development
Table 98. Bio-Techne Company Details
Table 99. Bio-Techne Business Overview
Table 100. Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 101. Bio-Techne Recent Development
Table 102. Exovita biosciences Company Details
Table 103. Exovita biosciences Business Overview
Table 104. Exovita biosciences Diagnostic Exosome Biomarker Product
Table 105. Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 106. Exovita biosciences Recent Development
Table 107. Immune Therapy Holdings Company Details
Table 108. Immune Therapy Holdings Business Overview
Table 109. Immune Therapy Holdings Diagnostic Exosome Biomarker Product
Table 110. Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 111. Immune Therapy Holdings Recent Development
Table 112. Lonza Company Details
Table 113. Lonza Business Overview
Table 114. Lonza Diagnostic Exosome Biomarker Product
Table 115. Lonza Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 116. Lonza Recent Development
Table 117. Norgen Biotek Company Details
Table 118. Norgen Biotek Business Overview
Table 119. Norgen Biotek Diagnostic Exosome Biomarker Product
Table 120. Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 121. Norgen Biotek Recent Development
Table 122. ReNeuron Group Company Details
Table 123. ReNeuron Group Business Overview
Table 124. ReNeuron Group Diagnostic Exosome Biomarker Product
Table 125. ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 126. ReNeuron Group Recent Development
Table 127. Therapeutic Solutions International Company Details
Table 128. Therapeutic Solutions International Business Overview
Table 129. Therapeutic Solutions International Diagnostic Exosome Biomarker Product
Table 130. Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2016-2021) & (US$ Million)
Table 131. Therapeutic Solutions International Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Exosome Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Membrane-bound Proteins Features
Figure 3. Soluble Proteins Features
Figure 4. Noncoding RNA Features
Figure 5. Others Features
Figure 6. Global Diagnostic Exosome Biomarker Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diagnostic Exosome Biomarker Report Years Considered
Figure 11. Global Diagnostic Exosome Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diagnostic Exosome Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diagnostic Exosome Biomarker Market Share by Regions: 2020 VS 2027
Figure 14. Global Diagnostic Exosome Biomarker Market Share by Regions (2022-2027)
Figure 15. Global Diagnostic Exosome Biomarker Market Share by Players in 2020
Figure 16. Global Top Diagnostic Exosome Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Exosome Biomarker as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diagnostic Exosome Biomarker Revenue in 2020
Figure 18. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2016-2021)
Figure 19. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2022-2027)
Figure 20. North America Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diagnostic Exosome Biomarker Market Share by Type (2016-2027)
Figure 22. North America Diagnostic Exosome Biomarker Market Share by Application (2016-2027)
Figure 23. North America Diagnostic Exosome Biomarker Market Share by Country (2016-2027)
Figure 24. United States Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diagnostic Exosome Biomarker Market Share by Type (2016-2027)
Figure 28. Europe Diagnostic Exosome Biomarker Market Share by Application (2016-2027)
Figure 29. Europe Diagnostic Exosome Biomarker Market Share by Country (2016-2027)
Figure 30. Germany Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diagnostic Exosome Biomarker Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diagnostic Exosome Biomarker Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diagnostic Exosome Biomarker Market Share by Region (2016-2027)
Figure 40. China Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diagnostic Exosome Biomarker Market Share by Type (2016-2027)
Figure 48. Latin America Diagnostic Exosome Biomarker Market Share by Application (2016-2027)
Figure 49. Latin America Diagnostic Exosome Biomarker Market Share by Country (2016-2027)
Figure 50. Mexico Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diagnostic Exosome Biomarker Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diagnostic Exosome Biomarker Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diagnostic Exosome Biomarker Market Share by Country (2016-2027)
Figure 56. Turkey Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diagnostic Exosome Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. 101Bio Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 60. AMS Biotechnology Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 61. BioRegenerative Sciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 62. Cell Guidance Systems Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 63. Codiak BioSciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 64. Evomic Science Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 65. ExoCyte Therapeutics Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 66. Bio-Techne Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 67. Exovita biosciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 68. Immune Therapy Holdings Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 69. Lonza Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 70. Norgen Biotek Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 71. ReNeuron Group Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 72. Therapeutic Solutions International Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---